Role of Albumin Treatment in Patients With Spontaneous Bacterial Peritonitis  Maria Poca, Mar Concepción, Meritxell Casas, Cristina Álvarez–Urturi, Jordi Gordillo, Virginia Hernández–Gea, Eva Román, Carlos Guarner–Argente, Ignasi Gich, German Soriano, Carlos Guarner  Clinical Gastroenterology and Hepatology  Volume 10, Issue 3, Pages 309-315 (March 2012) DOI: 10.1016/j.cgh.2011.11.012 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Renal failure and in-hospital mortality in low-risk (urea <11 mmol/L and bilirubin <68 μmol/L) versus high-risk episodes (urea ≥11 mmol/L and/or bilirubin ≥68 μmol/L), treated with albumin versus nontreated. Data are presented as frequencies (%). #Excluding cases with renal failure (creatinine >133 μmol/L) at SBP diagnosis. *P < .001 and **P = .001 compared with low-risk group. ¶P = .05 and ¶¶P = .02 compared with high-risk treated with albumin. Clinical Gastroenterology and Hepatology 2012 10, 309-315DOI: (10.1016/j.cgh.2011.11.012) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Probability of survival in (A) low risk versus high risk of mortality episodes; (B) high risk of mortality episodes treated and nontreated with albumin. Clinical Gastroenterology and Hepatology 2012 10, 309-315DOI: (10.1016/j.cgh.2011.11.012) Copyright © 2012 AGA Institute Terms and Conditions